VRHI (Veri Medtech Holdings) EBITDA Margin %: -65.31% (As of Dec. 2021)


VRHI Veri Medtech Holdings Inc VRHI
35 GF Score
Price $1.95
View Full Analysis

What is Veri Medtech Holdings EBITDA Margin %?

Veri Medtech Holdings VRHI 35 EBITDA Margin % is -65.31% as of Dec. 2021. GuruFocus rates VRHI with a GF Score™ of 35/100.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Veri Medtech Holdings's EBITDA for the six months ended in Dec. 2021 was $-0.03 Mil. Veri Medtech Holdings's Revenue for the six months ended in Dec. 2021 was $0.05 Mil. Therefore, Veri Medtech Holdings's EBITDA margin for the quarter that ended in Dec. 2021 was -65.31%.


Veri Medtech Holdings  (OTCPK:VRHI) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Veri Medtech Holdings EBITDA Margin % Related Terms


Veri Medtech Holdings EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Veri Medtech Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veri Medtech Holdings EBITDA Margin % Chart

Veri Medtech Holdings Annual Data
Trend Dec21
EBITDA Margin %
-65.31

Veri Medtech Holdings Semi-Annual Data
Dec21
EBITDA Margin % -65.31

VRHI vs MMVVF, BLMZ, MVNC: EBITDA Margin % Comparison

For the Health Information Services subindustry, Veri Medtech Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Veri Medtech Holdings EBITDA Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Veri Medtech Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Veri Medtech Holdings's EBITDA Margin % falls into.


VRHI
35GF Score
Veri Medtech Holdings Inc VRHI
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veri Medtech Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Veri Medtech Holdings's EBITDA Margin % for the fiscal year that ended in Dec. 2021 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2021 )/Revenue (A: Dec. 2021 )
=-0.032/0.049
=-65.31 %

Veri Medtech Holdings's EBITDA Margin % for the quarter that ended in Dec. 2021 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2021 )/Revenue (Q: Dec. 2021 )
=-0.032/0.049
=-65.31 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -65.31% mean?
Veri Medtech Holdings (VRHI) has a EBITDA Margin % of -65.31% as of Dec. 2021. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Veri Medtech Holdings and its competitors.
Is Veri Medtech Holdings' EBITDA Margin % too high?
Veri Medtech Holdings' current EBITDA Margin % is -65.31%. Overall, Veri Medtech Holdings has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Veri Medtech Holdings' EBITDA Margin % compare to MMVVF and BLMZ?
Veri Medtech Holdings' EBITDA Margin % of -65.31% can be compared against companies in the Healthcare Providers & Services industry. The industry median EBITDA Margin % is 10.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Veri Medtech Holdings and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Veri Medtech Holdings's current EBITDA Margin % is -65.31%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veri Medtech Holdings stock overvalued right now?
Veri Medtech Holdings (VRHI) has a current EBITDA Margin % of -65.31%. The current EBITDA Margin % is -65.31%. Veri Medtech Holdings' overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Veri Medtech Holdings (VRHI), the current EBITDA Margin % is -65.31% as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Veri Medtech Holdings Business Description

Address 1660 International Drive, Suite 600, McClean, VA, USA, 22101
Veri Medtech Holdings Inc is a healthcare technology company that offers alternative medicine, personalized diagnostics, and wellness medication on demand. The company leverages telehealth infrastructure, diagnostic intelligence, and scalable digital systems to meet the growing demand for accessible, stigma-free healthcare. Strategically positioned for growth, Veri MedTech actively explores acquisitions that complement its core capabilities and enhance patient engagement across emerging sectors of alternative medicine, longevity, and wellness science. With an integration and operational efficiency track record, the company drives accelerated revenue through the continuous generation of high-value patient databases and recurring service models.
35GF Score

Get the complete analysis for VRHI

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.95
Price